Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4662 | 1 | 1 |
Mycobacterium tuberculosis | Probable conserved lipoprotein LpqD | 0.0079 | 0.0055 | 0.5 |
Mycobacterium leprae | Possible phosphoglycerate mutase | 0.0079 | 0.0055 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0079 | 0.0055 | 0.5 |
Brugia malayi | phosphoglycerate mutase family protein | 0.0079 | 0.0055 | 0.1345 |
Schistosoma mansoni | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Schistosoma mansoni | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Mycobacterium tuberculosis | Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) | 0.0079 | 0.0055 | 0.5 |
Echinococcus granulosus | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Echinococcus multilocularis | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Brugia malayi | Pre-SET motif family protein | 0.0242 | 0.041 | 1 |
Brugia malayi | phosphoglycerate mutase family protein | 0.0079 | 0.0055 | 0.1345 |
Echinococcus granulosus | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Mycobacterium ulcerans | hypothetical protein | 0.2751 | 0.5854 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0079 | 0.0055 | 0.5 |
Mycobacterium tuberculosis | Possible phosphoglycerate mutase Gpm2 (phosphoglyceromutase) (PGAM) (BPG-dependent PGAM) | 0.0079 | 0.0055 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.2751 | 0.5854 | 1 |
Onchocerca volvulus | 0.4662 | 1 | 1 | |
Mycobacterium tuberculosis | Conserved protein | 0.0079 | 0.0055 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4662 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4662 | 1 | 1 |
Trichomonas vaginalis | set domain proteins, putative | 0.0276 | 0.0483 | 1 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0079 | 0.0055 | 0.5 |
Mycobacterium leprae | probable isochorismate synthase EntC | 0.0079 | 0.0055 | 0.5 |
Echinococcus multilocularis | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1989 | 0.4201 | 0.4169 |
Echinococcus multilocularis | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Mycobacterium tuberculosis | PE-PGRS family protein PE_PGRS11 | 0.0079 | 0.0055 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Echinococcus multilocularis | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Echinococcus multilocularis | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.4662 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.4662 | 1 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.2751 | 0.5854 | 1 |
Mycobacterium leprae | PROBABLE PHOSPHOGLYCERATE MUTASE 1 GPM1 (PHOSPHOGLYCEROMUTASE) (PGAM) (BPG-DEPENDENT PGAM) | 0.0079 | 0.0055 | 0.5 |
Echinococcus granulosus | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.4583 | 0.9829 | 0.9828 |
Schistosoma mansoni | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0079 | 0.0055 | 0.5 |
Plasmodium falciparum | phosphoglucomutase-2 | 0.0079 | 0.0055 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.4583 | 0.9829 | 0.9829 |
Mycobacterium leprae | conserved hypothetical protein | 0.0079 | 0.0055 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Treponema pallidum | phosphoglyceromutase | 0.0079 | 0.0055 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.1989 | 0.4201 | 0.4169 |
Plasmodium falciparum | phosphoglycerate mutase, putative | 0.0079 | 0.0055 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4583 | 0.9829 | 0.9828 |
Schistosoma mansoni | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.4583 | 0.9829 | 0.9828 |
Plasmodium vivax | phosphoglycerate mutase, putative | 0.0079 | 0.0055 | 0.5 |
Onchocerca volvulus | 0.0276 | 0.0483 | 0.043 | |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.4583 | 0.9829 | 0.9828 |
Echinococcus multilocularis | serine:threonine protein phosphatase PGAM5 | 0.0079 | 0.0055 | 0.0055 |
Chlamydia trachomatis | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase | 0.0079 | 0.0055 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1989 | 0.4201 | 0.4169 |
Echinococcus granulosus | serine:threonine protein phosphatase PGAM5 | 0.0079 | 0.0055 | 0.0055 |
Toxoplasma gondii | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.5 |
Brugia malayi | UBASH3A protein homolog | 0.0079 | 0.0055 | 0.1345 |
Echinococcus granulosus | serine:threonine protein phosphatase PGAM5 | 0.0079 | 0.0055 | 0.0055 |
Toxoplasma gondii | phosphoglycerate mutase PGMII | 0.0079 | 0.0055 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4662 | 1 | 1 |
Mycobacterium leprae | Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) | 0.0079 | 0.0055 | 0.5 |
Schistosoma mansoni | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.2673 | 0.5684 | 0.5684 |
Echinococcus granulosus | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Mycobacterium leprae | PROBABLE PHOSPHOGLYCERATE MUTASE (PHOSPHOGLYCEROMUTASE) | 0.0079 | 0.0055 | 0.5 |
Mycobacterium tuberculosis | Glucosyl-3-phosphoglycerate phosphatase GpgP | 0.0079 | 0.0055 | 0.5 |
Loa Loa (eye worm) | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Echinococcus multilocularis | serine:threonine protein phosphatase PGAM5 | 0.0079 | 0.0055 | 0.0055 |
Schistosoma mansoni | 6-phosphofructokinase | 0.4662 | 1 | 1 |
Echinococcus multilocularis | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Schistosoma mansoni | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Giardia lamblia | Hypothetical protein | 0.2751 | 0.5854 | 0.5 |
Echinococcus granulosus | phosphoglycerate mutase | 0.0079 | 0.0055 | 0.0055 |
Mycobacterium tuberculosis | Conserved protein | 0.0079 | 0.0055 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.0055 | 0.0055 |
Mycobacterium tuberculosis | Possible hydrolase MutT1 | 0.0079 | 0.0055 | 0.5 |
Plasmodium vivax | phosphoglucomutase-2, putative | 0.0079 | 0.0055 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0079 | 0.0055 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0079 | 0.0055 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.2751 | 0.5854 | 0.5 |
Mycobacterium leprae | POSSIBLE HYDROLASE MUTT1 | 0.0079 | 0.0055 | 0.5 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0242 | 0.041 | 0.041 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1989 | 0.4201 | 0.4169 |
Mycobacterium leprae | conserved hypothetical protein | 0.0079 | 0.0055 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 93.52 % | Analgesic activity in Kunming Mus musculus (mouse) assessed as increase in pain threshold at 200 mg/kg, po after 1 hr by hot plate method (Rvb = 4.2%) | ChEMBL. | No reference |
Inhibition (functional) | = 24.49 % | Anti-inflammatory activity in Kunming Mus musculus (mouse) assessed as inhibition of xylene-induced ear swelling at 200 mg/kg, po administered 1 hr prior to xylene challenge measured after 30 min relative to untreated control | ChEMBL. | No reference |
Inhibition (functional) | = 74.17 % | Analgesic activity in Kunming Mus musculus (mouse) assessed as inhibition of acetic acid-induced writhing at 200 mg/kg, po administered 1 hr prior to acetic acid challenge measured for 15 min relative to untreated control | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.